Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | POLA1 | P09884 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16867576 | 1.00 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL17690438 | 1.00 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL14733287 | 1.00 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL27653731 | 1.00 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL15964153 | 1.00 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL14733290 | 0.95 | MEN1 (0.53) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| Ether SCHEMBL7704702 | 0.93 | MEN1 (0.51) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL9735130 | 0.93 | MEN1 (0.54) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL28709667 | 0.92 | TSHR (0.58) | MEN1KMT2AL3MBTL1PPARGLMNA | |
| SCHEMBL1902134 | 0.91 | L3MBTL1 (0.55) | MEN1KMT2AL3MBTL1PPARGLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110283641-B | Electrostatic spraying anti-rust oil for cold-rolled steel sheets and preparation and performance test methods thereof | 清华大学天津高端装备研究院 | 2022-03-01 | — | — | CN | claimed |
| CN-112266832-B | Semiconductor chip cleaning agent, preparation method and application | 江苏奥首材料科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-112266832-A | Semiconductor chip cleaning agent, preparation method and application | 江苏奥首材料科技有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-110283641-A | A kind of cold-rolled steel sheet is electrostatically sprayed antirust oil and its preparation and performance test methods | 清华大学天津高端装备研究院 | 2019-09-27 | — | — | CN | claimed |
| US-9822056-B2 | Process for preparing a carboxylic acid | AVRIL (FR) | 2017-11-21 | — | — | US | claimed |
| US-20160326084-A1 | Process For Preparing A Carboxylic Acid | AVRIL (FR) | 2016-11-10 | — | — | US | claimed |
| CN-103484222-B | Rust preventive oil for electrostatic spraying | WUHAN IRON & STEEL GROUP CORP | 2015-03-25 | — | — | CN | claimed |
| CN-103965796-A | Formaldehyde-free wood adhesive film | YANG XUERONG | 2014-08-06 | — | — | CN | claimed |
| CN-103484222-A | Rust preventive oil for electrostatic spraying | WUHAN IRON & STEEL GROUP CORP | 2014-01-01 | — | — | CN | claimed |
| CN-101177392-A | Method for preparing 9,10-dihydroxystearic acid and its methyl by hydrogen dioxide oxidation process | XINJIANG PHYSICAL AND CHEMICAL (CN) | 2008-05-14 | — | — | CN | claimed |
| US-5852080-A | Hot melt adhesives with compatible hydroxyl-containing ester waxes | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1998-12-22 | — | — | US | claimed |
| US-5538550-A | MELTING, BUBBLES | CANON KABUSHIKI KAISHA (JP) | 1996-07-23 | — | — | US | claimed |
| EP-0654353-A2 | Jet recording method, normally solid recording material and recording apparatus for the method | CANON KABUSHIKI KAISHA (JP) | 1995-05-24 | — | — | EP | claimed |
| EP-0479501-A2 | Jet recording method, normally solid recording material and recording apparatus for the method | CANON KABUSHIKI KAISHA (JP) | 1992-04-08 | — | — | EP | claimed |
| EP-4692059-A1 | CATIONIC LIPID HAVING DISULFIDE BOND | Tohoku University (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| WO-2024203577-A1 | CATIONIC LIPID HAVING DISULFIDE BOND | 国立大学法人東北大学 | 2024-10-03 | — | — | WO | disclosed |
| US-4093637-A | REACTING FORMYLSTEARIC ACID OR ITS ESTERS WITH FORMALDEHYDE FOLLOWED BY ESTERIFICATION, ACYLATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1978-06-06 | — | — | US | disclosed |
| US-4083816-A | Acetoxymethyl derivatives of polyunsaturated fatty triglycerides as primary plasticizers for polyvinylchloride | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1978-04-11 | — | — | US | disclosed |
| US-3978225-A | ANTIPROSTAGLANDIN, ANTIDIARRHEA | SMITHKLINE CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326084-A1 | Process For Preparing A Carboxylic Acid | HAO2, PCCA, OGDH | MEN1 2305/4885KMT2A 1889/4885L3MBTL1 4627/4885 |
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | LY96, CD74, TLR9 | MEN1 2949/4885KMT2A 1335/4885L3MBTL1 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.